Literature DB >> 29487207

How many patients could benefit from REBOA in prehospital care? A retrospective study of patients rescued by the doctors of the Paris fire brigade.

Oscar Thabouillot1, K Bertho1, E Rozenberg1, N-C Roche2, G Boddaert3, D Jost1, J-P Tourtier1.   

Abstract

INTRODUCTION: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a technique to control haemorrhage by placing a retrograde catheter in an artery and inflating a balloon at its tip. This retrospective study aimed to evaluate the proportion of injured people who could potentially have benefited from this technique prior to hospitalisation, including on the scene or during transport.
METHODS: A retrospective analysis was conducted of all patients with trauma registered in the Paris Fire Brigade emergency medical system between 1 January and 31 December 2014. Inclusion criteria included all patients over 18 years of age with bleeding of supposedly abdominal and/or pelvic and/or junctional origin, uncontrolled haemorrhagic shock or cardiac arrest with attempted resuscitation.
RESULTS: During this study period, a total of 1159 patients with trauma (3.2%) would have been eligible to undergo REBOA. Death on scene rate was 83.8% (n=31) and six patients had a beating heart when they arrived at the hospital. Ten out of the 37 patients had spontaneous circulatory activity. Among them, four people died on the scene or during transport. Thirty-six out of 37 patients were intubated, one benefited from the use of a haemostatic dressing and one benefited from a tourniquet.
CONCLUSIONS: REBOA can be seen as an effective non-surgical solution to ensure complete haemostasis during the prehospital setting. When comparing the high mortality rate following haemorrhage with the REBOA's rare side effects, the risk-benefit balance is positive. Given that 3% of all patients with trauma based on this study would have been eligible for REBOA, we believe that this intervention should be available in the prehospital setting. The results of this study will be used: educational models for REBOA balloon placement using training manikins, with an ultimate aim to undertake a prospective feasibility study in the prehospital setting. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  trauma management; wound management

Mesh:

Year:  2018        PMID: 29487207     DOI: 10.1136/jramc-2018-000915

Source DB:  PubMed          Journal:  J R Army Med Corps        ISSN: 0035-8665            Impact factor:   1.285


  4 in total

1.  Needs assessment of resuscitative endovascular balloon occlusion of the aorta (REBOA) in patients with major haemorrhage: a cross-sectional study.

Authors:  Bård Neuenkirchen Godø; Jostein Rodseth Brede; Andreas Jorstad Krüger
Journal:  Emerg Med J       Date:  2021-05-26       Impact factor: 3.814

2.  Technical limitations of REBOA in a patient with exsanguinating pelvic crush trauma: a case report.

Authors:  Orkun Özkurtul; Holger Staab; Georg Osterhoff; Benjamin Ondruschka; Andreas Höch; Christoph Josten; Johannes Karl Maria Fakler
Journal:  Patient Saf Surg       Date:  2019-06-24

Review 3.  Resuscitative endovascular balloon occlusion of the aorta in civilian pre-hospital care: a systematic review of the literature.

Authors:  Yaset Caicedo; Linda M Gallego; Hugo Jc Clavijo; Natalia Padilla-Londoño; Cindy-Natalia Gallego; Isabella Caicedo-Holguín; Mónica Guzmán-Rodríguez; Juan J Meléndez-Lugo; Alberto F García; Alexander E Salcedo; Michael W Parra; Fernando Rodríguez-Holguín; Carlos A Ordoñez
Journal:  Eur J Med Res       Date:  2022-10-17       Impact factor: 4.981

4.  Use of bilobed partial resuscitative endovascular balloon occlusion of the aorta is logistically superior in prolonged management of a highly lethal aortic injury.

Authors:  Jevgenia Zilberman-Rudenko; Brandon Behrens; Belinda McCully; Elizabeth N Dewey; Sawyer G Smith; James M Murphy; Andrew Goodman; Samantha J Underwood; Elizabeth A Rick; Brianne M Madtson; Michelle E Thompson; Jacob J Glaser; John B Holcomb; Martin A Schreiber
Journal:  J Trauma Acute Care Surg       Date:  2020-09       Impact factor: 3.697

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.